Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
about
Making sense of big data in health research: Towards an EU action planMAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.
P2860
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@ast
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@en
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@nl
type
label
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@ast
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@en
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@nl
prefLabel
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@ast
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@en
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@nl
P2860
P3181
P1476
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer
@en
P2093
Edward J Kim
Thomas J Semrad
P2860
P304
P3181
P356
10.3978/J.ISSN.2078-6891.2015.094
P407
P433
P577
2016-04-01T00:00:00Z